United States · FDA National Drug Code directory
Zegalogue
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0169-1913_df9fed8a-f13a-4ef4-90cc-8ba51909d30c
- Product NDC
- 0169-1913
- Form
- INJECTION, SOLUTION
- Composition / generic term
- dasiglucagon
- Labeler
- Novo Nordisk
- Marketing category
- NDA
- Marketing start / end (source format)
- 20230626 / 20270831
Source-listed ingredients
- DASIGLUCAGON — .6 mg/.6mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CONTAINER in 1 PACKAGE (0169-1913-01) / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS · 0169-1913-01
- 2 PACKAGE in 1 CARTON (0169-1913-02) / 1 CONTAINER in 1 PACKAGE (0169-1913-12) / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS · 0169-1913-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →